Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,931 | -97,336 | -61,656 | -30,070 | -4,259 |
| Depreciation Amortization | 2,078 | -1,226 | -918 | 183 | 233 |
| Accounts receivable | N/A | 174 | 1,427 | 3,742 | -4,117 |
| Other Working Capital | -7,829 | 15,958 | 3,461 | 4,075 | -7,026 |
| Other Operating Activity | 11,525 | 12,913 | 9,180 | 2,632 | 6,139 |
| Operating Cash Flow | $-14,157 | $-69,517 | $-48,506 | $-19,438 | $-9,030 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -569 | -805 | -1,063 | -290 | -50 |
| Purchase Of Investment | -194,927 | -251,815 | -347,537 | -290,905 | N/A |
| Sale Of Investment | 289,971 | 384,051 | 206,149 | 48,137 | N/A |
| Investing Cash Flow | $94,475 | $131,431 | $-142,451 | $-243,058 | $-50 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 10,000 |
| Common Stock Issued | 496 | 3,007 | 230,421 | 294,052 | 31 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -1 |
| Other Financing Activity | -1,375 | -7,500 | -7,057 | -1,599 | -1,402 |
| Financing Cash Flow | $-879 | $-4,493 | $223,364 | $292,453 | $8,628 |
| Beginning Cash Position | 171,077 | 113,656 | 81,249 | 51,292 | 51,744 |
| End Cash Position | 250,516 | 171,077 | 113,656 | 81,249 | 51,292 |
| Net Cash Flow | $79,439 | $57,421 | $32,407 | $29,957 | $-452 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,157 | -69,517 | -48,506 | -19,438 | -9,030 |
| Capital Expenditure | -569 | -805 | -1,063 | -290 | -50 |
| Free Cash Flow | -14,726 | -70,322 | -49,569 | -19,728 | -9,080 |